Hemodynamic effects of atrial natriuretic factor in young and elderly subjects
- PMID: 2143129
- DOI: 10.1038/clpt.1990.133
Hemodynamic effects of atrial natriuretic factor in young and elderly subjects
Abstract
Because levels of plasma atrial natriuretic factor (ANF) increase with advancing age, a diminished hemodynamic responsiveness to ANF in the elderly has been hypothesized in the literature. Therefore hemodynamic effects after two infusion rates (0.25 and 2.0 micrograms/min) of atrial natriuretic factor (99-126) were investigated in young (n = 8) and elderly (n = 9) volunteers in a double-blind, randomized, and placebo-controlled protocol. After low-rate infusion, ANF concentrations increased to the upper normal range, and only minor effects were observed. In contrast, high-rate infusion resulted in a decrease in blood pressure and forearm vascular resistance, whereas an increase in heart rate was observed in both groups. Between young and elderly subjects, a significant difference was observed in the ANF-induced decrease in systolic blood pressure (mean +/- SD, -4% +/- 4% versus -12% +/- 7%, p less than 0.05) and mean arterial pressure (-6% +/- 5% versus -11% +/- 4%, p less than 0.05) during the high rate infusion. When compared with the concentrations of the young subjects, the ANF concentrations reached at both ANF dosages were higher in the elderly subjects; this was the result of a diminished ANF clearance in the elderly subjects. After correction of the changes of systolic blood pressure and mean arterial pressure for the higher ANF levels reached within this elderly group, no difference between young and elderly subjects remained. We conclude that a diminished cardiovascular responsiveness to ANF with advancing age could not be demonstrated. In contrast, the high-rate infusion of ANF induced an increased hemodynamic response in the elderly subjects, but this seems to be the result of the higher ANF levels reached within this group.
Similar articles
-
Age-dependent vasodilation of the skin microcirculation by atrial natriuretic factor.J Cardiovasc Pharmacol. 1991 Oct;18(4):622-30. doi: 10.1097/00005344-199110000-00020. J Cardiovasc Pharmacol. 1991. PMID: 1724541 Clinical Trial.
-
Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.J Cardiovasc Pharmacol. 1992 May;19(5):691-700. J Cardiovasc Pharmacol. 1992. PMID: 1381766
-
Effects of ANF infusion on the renal responses to lower-body negative pressure in humans.J Cardiovasc Pharmacol. 1998 May;31(5):669-76. doi: 10.1097/00005344-199805000-00004. J Cardiovasc Pharmacol. 1998. PMID: 9593065
-
Renal hemodynamic and natriuretic effects of atrial natriuretic factor.Fed Proc. 1986 Jun;45(7):2128-32. Fed Proc. 1986. PMID: 3011521 Review.
-
Atrial natriuretic factor and transgenic mice.Hypertension. 1993 Oct;22(4):634-9. doi: 10.1161/01.hyp.22.4.634. Hypertension. 1993. PMID: 8406670 Review.
Cited by
-
Kinetics of atrial natriuretic peptide in young and elderly subjects.Eur J Clin Pharmacol. 1992;42(4):449-52. doi: 10.1007/BF00280134. Eur J Clin Pharmacol. 1992. PMID: 1387608
-
Age-related changes in the renin-aldosterone system. Physiological effects and clinical implications.Drugs Aging. 1993 May-Jun;3(3):238-45. doi: 10.2165/00002512-199303030-00005. Drugs Aging. 1993. PMID: 8324299 Review.
-
Sodium disorders in the elderly.J Natl Med Assoc. 2005 Feb;97(2):217-24. J Natl Med Assoc. 2005. PMID: 15712785 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical